Widely used:Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
$576 Mln
P/E Ratio
--
P/B Ratio
1.84
Industry P/E
50.85
Debt to Equity
0.67
ROE
-0.48 %
ROCE
--
Div. Yield
0 %
Book Value
--
EPS
--
CFO
$-233.54 Mln
EBITDA
$-184.07 Mln
Net Profit
$-902.38 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Accolade Inc (ACCD)
| 105.26 | 0.72 | 109.55 | -23.61 | -24.08 | -- | -- |
|
BSE Sensex*
| 0.39 | 6.40 | 1.96 | 7.69 | 10.43 | 20.75 | 10.61 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
|
|---|---|---|---|---|
|
Accolade Inc (ACCD)
| -71.23 | 54.17 | -70.45 | -39.40 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 140.03 | 11,320.00 | 13.19 | 159.08 | |
| 103.35 | 10,373.03 | 22.94 | 24.54 | |
| 121.81 | 11,366.20 | 3.68 | 110.75 | |
| 174.80 | 11,323.10 | 10.33 | 17.71 |
Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the... United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions. In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions. It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs. The company was incorporated in 2007 and is headquartered in Seattle, Washington. Address: 1201 Third Avenue, Seattle, WA, United States, 98101 Read more
Chairman of the Board & CEO
Mr. Rajeev Singh
Chairman of the Board & CEO
Mr. Rajeev Singh
Headquarters
Seattle, WA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Accolade Inc (ACCD) stood at $ 751 Mln as on 30-Nov-24
The share price of Accolade Inc (ACCD) is $7.02 (NASDAQ) as of 08-Apr-2025 09:30 EDT. Accolade Inc (ACCD) has given a return of -24.08% in the last 3 years.
Accolade Inc (ACCD) has a market capitalisation of $ 576 Mln as on 08-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Accolade Inc (ACCD) is 1.84 times as on 08-Apr-2025, a 31% discount to its peers’ median range of 2.65 times.
Since, TTM earnings of Accolade Inc (ACCD) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Accolade Inc (ACCD) and enter the required number of quantities and click on buy to purchase the shares of Accolade Inc (ACCD).
Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions. In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions. It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs. The company was incorporated in 2007 and is headquartered in Seattle, Washington. Address: 1201 Third Avenue, Seattle, WA, United States, 98101
The CEO & director of Mr. Rajeev Singh. is Accolade Inc (ACCD), and CFO & Sr. VP is Mr. Rajeev Singh.
There is no promoter pledging in Accolade Inc (ACCD).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,137
|
|
|
1,132
|
|
|
1,132
|
|
|
1,037
|
| Accolade Inc (ACCD) | Ratios |
|---|---|
|
Return on equity(%)
|
-48.19
|
|
Operating margin(%)
|
-20.01
|
|
Net Margin(%)
|
-40.36
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Accolade Inc (ACCD) was $0 Mln.
